Provided by Tiger Fintech (Singapore) Pte. Ltd.

TriSalus Life Sciences Inc.

4.18
-0.0500-1.18%
Post-market: 4.180.00000.00%16:10 EDT
Volume:60.25K
Turnover:253.10K
Market Cap:158.17M
PE:-3.67
High:4.31
Open:4.18
Low:4.05
Close:4.23
Loading ...

Lake Street Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)

TIPRANKS
·
25 Jul

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series a Convertible Preferred Stock

THOMSON REUTERS
·
25 Jul

TriSalus Life Sciences Completes Conversion of Preferred Shares, Announces Results of Exchange Offer

Reuters
·
25 Jul

TriSalus Life Sciences Inc. Files Initial Statement of Beneficial Ownership for CFO David Patience

Reuters
·
11 Jul

Lake Street Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)

TIPRANKS
·
24 Jun

TriSalus Life Sciences Announces Plan to Convert Preferred Shares to Common Stock, Streamlining Capital Structure

Reuters
·
24 Jun

TriSalus Life Sciences Inc. Conducted Annual Shareholder Meeting

Reuters
·
17 Jun

TriSalus Life Sciences (TLSI) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
09 Jun

TriSalus Life Sciences Unveils TriNav FLX Infusion System with Enhanced Trackability and Precision for Solid Tumor Treatment

Reuters
·
04 Jun

TriSalus Life Sciences (TLSI) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
02 Jun

TriSalus Life Sciences files to sell 5.5M shares of common stock for holders

TIPRANKS
·
31 May

TriSalus Life Sciences Inc. Files Amendment to 10-K Annual Report

Reuters
·
31 May

TriSalus Life Sciences Appoints David B. Patience as New CFO Amid Leadership Transition

Reuters
·
30 May

Chief Regulatory Officer Jennifer Stevens Reports Disposal of Trisalus Life Sciences Inc. Common Shares

Reuters
·
22 May

Roth MKM Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)

TIPRANKS
·
21 May

TriSalus Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

BRIEF-Trisalus Life Sciences Q1 Pretax Profit USD -10.37 Million

Reuters
·
15 May

TriSalus Life Sciences Q1 EPS $(0.39) Misses $(0.23) Estimate, Sales $9.17M Beat $9.04M Estimate

Benzinga
·
15 May

TriSalus Life Sciences Reports 42% Revenue Growth in Q1 2025, Reduces Operating Losses to $7.3 Million

Reuters
·
15 May

Press Release: TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

Dow Jones
·
15 May